| 摘要: |
| ［摘要］目的 评价对老年慢性心力衰竭（CHF）患者进行心脏康复（CR）的安全性．方法 连续选取60岁以上CHF患者72例，随机分为实验组（n＝35）和对照组（n＝37），实验组和对照组均严格按照指南进行治疗，实验组在药物治疗的基础上给予综合CR方案．随访12个月后全因死亡、心衰恶化再入院及严重不良事件的发生情况．结果（1）12个月后实验组较对照组全因死亡及心衰恶化再入院的发生例数降低（P＜0.05）；（2）严重不良事件的发生例数差异无统计学意义（P＞0.05）．结论 对老年CHF患者进行CR能够有效降低患者的全因死亡及心衰恶化再入院病例，而严重不良事件的发生并无明显增加，对老年CHF患者进行CR安全有效． |
| 关键词: ［关键词］心脏康复 慢性心力衰竭 临床评价 安全性 |
| DOI： |
| 分类号: |
| 基金项目:［基金项目］云南省应用基础研究基金资助项目（2010CD123） |
|
| Clinical Assessment on the Safety of Cardiac Rehabilitation for the Elderly Patients with Chronic Heart Failure |
|
LUO Yong-li
|
|
（The Third People’s Hospital of Yunnan Province，Kunming Yunnan 650011，China）
|
| Abstract: |
| ［Abstract］Objective To evaluate the safety of cardiac rehabilitation （CR） for the elderly patients with chronic heart failure（CHF）. Methods All 72 patients with CHF over the age of 60 were enrolled and randomly divided into two groups: the experimental groups（n＝35）and control groups（n＝37）. Patients in both groups were treated strictly according to the treatment guideline. On the basis of drug treatment， patients in experimental group were given a comprehensive CR program. The occurrence of all-cause death， due to deterioration of heart failure readmission and serious adverse events were compared after 12 months. Results Compared with the control group， the incidence of all-cause and the cases for the deterioration of heart failure readmission decreased in the experimental group after 12 months （P < 0.05）. There was no statistically significant difference in the occurrence of serious adverse events between the two groups（P > 0.05）. Conclusion For the elderly CHF patients， cardiac rehabilitation can effectively reduce all-cause death and deterioration of heart failure readmission in patients， but the serious adverse events had no obvious change. It is safe and effective for the elderly patients with chronic heart failure. |
| Key words: ［Key words］Cardiac rehabilitation Chronic heart failure Clinical assessment Safety |